Martin Dow Group

Martin Dow is one of Pakistan's largest healthcare conglomerates, with a legacy spanning over 60 years. The group operates as a fully integrated pharmaceutical organization, focusing on the development, manufacturing, and marketing of branded generics, nutraceuticals, and consumer health products, with cGMP-compliant facilities in Pakistan and France. The company has significantly expanded its footprint through strategic acquisitions, including the 2010 acquisition of Roche Pakistan's manufacturing assets and brand licenses, and the 2016 acquisition of Merck Pakistan's shareholding. Martin Dow maintains a strong presence in Asian and African markets and is committed to advancing healthcare access through innovation and high-quality therapeutic solutions.